Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology (NCT06753045)
Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology: HEARTBEAT
🩺 Plain-English Summary (8th-Grade Level)
This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 year period. Concurrent to smartwatch data collection, subjects will be instructed to complete questionnaires via the Huma Decentralized Clinical Trials (HUMADCT) platform. There are no investigational drugs or interventions administered as part of this study.
Who can join: Review the eligibility criteria below.
Location: East Jefferson General Hospital — New Orleans, Louisiana
Age range: 18 Years to 120 Years
🧪 Interventions in This Study
- Smartwatch (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- East Jefferson General Hospital — New Orleans, Louisiana
- Tulane University Medical Group Clinics — New Orleans, Louisiana
- University Medical Center — New Orleans, Louisiana
📞 Contact the Study Coordinator
Phone: (504) 988-3058
Email: heartbeat@tulane.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Diseases
- EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis — Phoenix, Arizona
- VWCR to Improve Cardiovascular Health and Outcomes Among Cardiac Patients: A Multicenter Randomized Clinical Trial Protocol (Destination Cardiac Rehab Study) — Irvine, California
- Sternal Plating High Risk — Cleveland, Ohio
- Gauging Outcomes of Total Milk Ingestion on Lipid and gControl — San Francisco, California
- Angiography and Electrogram Guided Bachmann Bundle Pacing — Wilkes-Barre, Pennsylvania
- MyGeneRank: A Digital Platform for Next-Generation Genetic Studies — La Jolla, California
Explore by condition: All Heart Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.